neoandrographolide,
Neoandrographolide,
27215-14-1,
Neoandrographiside,
UNII-XBY0Z806J2,
XBY0Z806J2,
CHEMBL480853,
MEGxp0_000981,
SCHEMBL2225354,
ACon1_000667,
HY-N0721,
8182AH,
MFCD07779130,
ZINC21992902,
AKOS030526126,
Neoandrographolide, analytical standard,
CS-3656,
MCULE-4819752182,
NCGC00169477-01,
NCGC00169477-02,
215N141,
W-202147,
BRD-K66516195-001-01-4,
2(5H)-Furanone, 3-(2-(5-((beta-D-glucopyranosyloxy)methyl)decahydro-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethyl)-, (1R-(1alpha,4abeta,5alpha,8aalpha))-,
NCGC00169477-02_C26H40O8_2(5H)-Furanone, 3-[2-[(1R,4aS,5R,8aS)-5-[(beta-D-glucopyranosyloxy)methyl]decahydro-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethyl]-,
C26H40O8,
ACN-046984,
C26-H40-O8,
CID9848024,
C082497,
2(5H)-Furanone, 3-(2-((1R,4aS,5R,8aS)-5-((beta-D-glucopyranosyloxy)methyl)decahydro-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethyl)-,